Nuveen Asset Management, LLC Viking Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 461,082 shares of VKTX stock, worth $23.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

461,082

Previous 267,620 72.29%

Holding current value

$23.8 Million

Previous $4.98 Million 659.2%

% of portfolio

0.01%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$17.4 - $94.5 $3.37 Million - $18.3 Million	193,462 Added 72.29%	461,082 $37.8 Million
Q4 2023 Feb 14, 2024	BUY	$9.24 - $19.64 $30,824 - $65,519	3,336 Added 1.26%	267,620 $4.98 Million
Q3 2023 Nov 14, 2023	SELL	$10.92 - $16.0 $3,396 - $4,976	-311 Reduced 0.12%	264,284 $2.93 Million
Q2 2023 Aug 14, 2023	BUY	$14.84 - $24.79 $3.73 Million - $6.24 Million	251,647 Added 1943.52%	264,595 $4.29 Million
Q1 2023 May 15, 2023	BUY	$8.08 - $17.33 $104,619 - $224,388	12,948 New	12,948 $215,000

Q2 2022 Aug 15, 2022	SELL	$2.11 - $3.15 $555,208 - $828,865	-263,132 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$3.0 - $4.88 $1.57 Million - $2.55 Million	-522,881 Reduced 66.52%	263,132 $855,000
Q4 2021 Feb 14, 2022	SELL	$4.6 - $6.72 $1.51 Million - $2.2 Million	-327,359 Reduced 29.4%	786,013 $3.57 Million
Q3 2021 Nov 12, 2021	BUY	$5.58 - $7.04 $4.63 Million - $5.84 Million	829,824 Added 292.66%	1,113,372 $7.45 Million
Q2 2021 Aug 16, 2021	SELL	$5.19 - $6.73 $68,559 - $88,903	-13,210 Reduced 4.45%	283,548 $1.7 Million
Q1 2021 May 17, 2021	SELL	$5.74 - $9.67 $76,123 - $128,243	-13,262 Reduced 4.28%	296,758 $1.88 Million
Q4 2020 Feb 16, 2021	SELL	$5.3 - $6.71 $1.01 Million - $1.28 Million	-191,168 Reduced 38.14%	310,020 $1.75 Million
Q3 2020 Nov 16, 2020	BUY	$5.73 - $8.11 $1.45 Million - $2.05 Million	252,718 Added 101.71%	501,188 $2.92 Million
Q2 2020 Aug 14, 2020	SELL	$4.35 - $8.08 $25,908 - $48,124	-5,956 Reduced 2.34%	248,470 $1.79 Million
Q1 2020 May 14, 2020	SELL	$3.45 - $7.95 $1,838 - $4,237	-533 Reduced 0.21%	254,426 $1.19 Million
Q4 2019 Feb 14, 2020	SELL	$6.38 - $8.73 $1.07 Million - $1.46 Million	-167,442 Reduced 39.64%	254,959 $2.05 Million
Q3 2019 Nov 14, 2019	BUY	$6.55 - $8.6 $942,387 - $1.24 Million	143,876 Added 51.66%	422,401 $2.91 Million
Q2 2019 Aug 15, 2019	BUY	$7.67 - $10.63 $2.14 Million - $2.96 Million	278,525 New	278,525 $2.31 Million
Q1 2019 May 14, 2019	SELL	$7.58 - $9.94 $628,836 - $824,622	-82,960 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$7.16 - $16.21 $391,873 - $887,189	54,731 Added 193.88%	82,960 $635,000
Q3 2018 Nov 13, 2018	BUY	$9.7 - $19.65 $273,821 - $554,699	28,229 New	28,229 $492,000

Others Institutions Holding VKTX

# of Institutions

426

Shares Held

63.1M

Call Options Held

7.39M

Put Options Held

5.13M

View Full List

About Viking Therapeutics, Inc.

Ticker VKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,688,496
Market Cap $3.95B
Description
Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...

More about VKTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Viking Therapeutics, Inc. Transaction History